Literature DB >> 18712445

The effects of adjuvant experimental radioimmunotherapy and hyperthermic intraperitoneal chemotherapy on intestinal and abdominal healing after cytoreductive surgery for peritoneal carcinomatosis in the rat.

F Aarts1, R P Bleichrodt, B de Man, R Lomme, O C Boerman, T Hendriks.   

Abstract

BACKGROUND: Cytoreductive surgery (CS) followed by hyperthermic intraperitoneal chemotherapy (HIPEC) results in limited survival benefit and high morbidity and mortality rates in patients with peritoneal carcinomatosis (PC). Radioimmunotherapy (RIT) after CS of experimental PC has been shown to increase survival and compare favorably to HIPEC. The effects of RIT and HIPEC on wound healing after CS need to be determined.
METHODS: PC was induced by intraperitoneal inoculation of CC-531 colon carcinoma cells in Wag/Rij rats. Animals were subjected to CS and anastomotic construction only or followed by RIT or HIPEC. RIT consisted of 74 MBq (177)lutetium-labeled anti-CC531 antibody MG1. HIPEC was performed by a closed abdominal perfusion technique using mitomycin-C during 60 minutes. Anastomotic and abdominal wall strength measurements were performed 3 and 5 days after surgery.
RESULTS: At day 5, bursting pressure in ileum and colon anastomoses in the CS + HIPEC group, but not in the CS + RIT group, was lower (P < .01) than in the CS group. In the CS group, the colonic bursting site was more often outside the true anastomotic area (8 of 12 animals) than in the CS + HIPEC (1 of 12) and CS + RIT (5 of 12) groups. Abdominal wall strength in the CS + HIPEC group was significantly (P < .01) lower, at both measuring points, than that in both the CS group and the CS + RIT group. There was no difference between the latter.
CONCLUSION: As adjuvant to CS, HIPEC showed a decrease in anastomotic and abdominal wall wound strength in a model of PC of CRC, whereas RIT did not.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18712445     DOI: 10.1245/s10434-008-0070-4

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  15 in total

1.  Early results on the use of biomaterials as adjuvant to abdominal wall closure following cytoreduction and hyperthermic intraperitoneal chemotherapy.

Authors:  Cherif Boutros; Ponandai Somasundar; N Joseph Espat
Journal:  World J Surg Oncol       Date:  2010-08-20       Impact factor: 2.754

2.  Establishment and identification of a rabbit model of peritoneal carcinomatosis from gastric cancer.

Authors:  Lie-Jun Mei; Xiao-Jun Yang; Li Tang; Alaa Hammed Al-Shammaa Hassan; Yutaka Yonemura; Yan Li
Journal:  BMC Cancer       Date:  2010-04-01       Impact factor: 4.430

3.  The effects of platelet-rich-plasma gel application to the colonic anastomosis in hyperthermic intraperitoneal chemotherapy: An experimental rat model.

Authors:  Sonmez Ocak; Omer F Buk; Bugra Genc; Bahattin Avcı; Hatice O Uzuner; Salih B Gundogdu
Journal:  Int Wound J       Date:  2019-08-25       Impact factor: 3.315

4.  Brief intraperitoneal radioimmunotherapy of small peritoneal carcinomatosis using high activities of noninternalizing 125I-labeled monoclonal antibodies.

Authors:  Vincent Boudousq; Stéphanie Ricaud; Véronique Garambois; Caroline Bascoul-Mollevi; Samir Boutaleb; Muriel Busson; François Quenet; Pierre-Emmanuel Colombo; Manuel Bardiès; Pierre-Olivier Kotzki; Isabelle Navarro-Teulon; André Pèlegrin; Jean-Pierre Pouget
Journal:  J Nucl Med       Date:  2010-10-18       Impact factor: 10.057

5.  Multimodal approach for treatment of peritoneal surface malignancies in a tumour-bearing rat model.

Authors:  Wieland Raue; Maik Kilian; Chris Braumann; Vladimir Atanassow; Anna Makareinis; Sonja Caldenas; Wolfgang Schwenk; Jens Hartmann
Journal:  Int J Colorectal Dis       Date:  2009-11-10       Impact factor: 2.571

6.  Noninternalizing monoclonal antibodies are suitable candidates for 125I radioimmunotherapy of small-volume peritoneal carcinomatosis.

Authors:  Lore Santoro; Samir Boutaleb; Véronique Garambois; Caroline Bascoul-Mollevi; Vincent Boudousq; Pierre-Olivier Kotzki; Monique Pèlegrin; Isabelle Navarro-Teulon; André Pèlegrin; Jean-Pierre Pouget
Journal:  J Nucl Med       Date:  2009-11-12       Impact factor: 10.057

Review 7.  Emerging trends for radioimmunotherapy in solid tumors.

Authors:  Maneesh Jain; Suprit Gupta; Sukhwinder Kaur; Moorthy P Ponnusamy; Surinder K Batra
Journal:  Cancer Biother Radiopharm       Date:  2013-07-11       Impact factor: 3.099

8.  Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival of gastric cancer with peritoneal carcinomatosis: evidence from an experimental study.

Authors:  Li Tang; Lie-Jun Mei; Xiao-Jun Yang; Chao-Qun Huang; Yun-Feng Zhou; Yutaka Yonemura; Yan Li
Journal:  J Transl Med       Date:  2011-05-07       Impact factor: 5.531

Review 9.  Optimization of drug delivery systems for intraperitoneal therapy to extend the residence time of the chemotherapeutic agent.

Authors:  L De Smet; W Ceelen; J P Remon; C Vervaet
Journal:  ScientificWorldJournal       Date:  2013-03-25

10.  Safe temperature range for intraoperative and early postoperative continuous hyperthermic intraperitoneal perfusion in a swine model of experimental distal gastrectomy with Billroth II reconstruction.

Authors:  Sheng Li; Yong-lei Zhang; Jia-yuan Sun; Ya-wei Hua; Pei-hong Wu
Journal:  J Transl Med       Date:  2013-07-29       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.